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ever, the impact of DXR on cardiac gene expression has been barely explored. DXR was found to inhibit DNA replication in cultured rat cardiomyocytes and to alter cardiac DNA in animals and humans, inducing cardiac-specific lesions (17, 31, 32, 49) . Development of DXR cardiotoxicity has been associated with important and relatively fast repression of several cardiac-specific genes (22, 25, 62) . The few earlier genomewide studies on the impact of DXR on the cardiac transcriptome focused either on single genes or selected pathways (5, 70) .
The present study aims at a global characterization of the early cardiac transcriptomic response to a low DXR dose to identify the most sensitive genes and groups of genes associated with specific functions or metabolic pathways. Such a systems biology approach is expected to contribute to our understanding of regulatory crosstalk between different involved mechanisms and to identify new elements possibly driving the development of chronic toxicity. The applied experimental model using isolated perfused rat heart together with a low clinically relevant DXR dose (2 M) has been characterized already in our previous study (60) . Under these experimental conditions, DXR accumulates very rapidly in cardiac nuclei and mitochondria and triggers inhibition of different kinase systems regulating cellular energy homeostasis (60) . In the current study, transcriptomic profiling was performed using both single gene and gene set enrichment analysis (GSEA), the latter being an analytical method to identify coordinated changes in functionally related groups of genes. In addition, energy metabolism was assessed by biochemical and functional assays. Besides confirming some known DXRresponding genes, which validates our approach, the study identified several new genes sensitive to DXR and yielded essentially a novel set of DXR-responding pathways. The latter included a detrimental downregulation of stress-responsive pathways and a modulation of the cardiac remodeling capacity, both potentially important for long-term effects.
MATERIALS AND METHODS

Chemicals
Doxorubicin hydrochloride (DXR) was obtained from Fluka (Buchs, Switzerland). Stock solutions of DXR at 10 mM were prepared in water, aliquoted, and kept frozen until use. Further dilutions were made in Krebs-Henseleit buffer containing 155 mM Na ϩ , 5.6 mM K ϩ , 138 mM Cl Ϫ , 2.1 mM Ca 2ϩ , 1.2 mM PO 4 3Ϫ , 25 mM HCO 3 Ϫ , 0.56 mM Mg 2ϩ , and 11 mM glucose directly before perfusion. ADP, phosphoenolpyruvate (PEP), and pyruvate kinase (PK) were obtained from Sigma (Steinheim, Germany); creatine (Cr) was obtained from Merck (Hohenbrunn, Germany); and ATP, NADP, glucose-6-phos-phate dehydrogenase, hexokinase, and creatine kinase was obtained from Roche (Mannheim, Germany).
Perfusion Protocol
Hearts from male Wistar rats (ϳ300 g) were perfused in a noncirculating Langendorff apparatus without (control) or with 2 M DXR during 2 h, and functional parameters were recorded as described earlier (60) . At the end of perfusion, depending on the experimental series, hearts were either rapidly frozen in liquid nitrogen and stored at Ϫ80°C for later analysis (gene and protein expression, metabolite analysis) or immediately used to prepare skinned fibers for respiratory measurements. At least four control and DXR-treated hearts were prepared in each series. All experiments involving animals were performed in compliance with the guidelines of the European Community and the Animal Care and Use Committee of the University of Zurich.
RNA Isolation, cDNA Synthesis, and Microarray Hybridization
Total RNA was extracted from control and DXR-treated samples using RNAeasy Mini kit (Qiagen, Hilden, Germany). The quality of the isolated RNA was determined with a NanoDrop ND 1000 (NanoDrop Technologies, Wilmington, DE) and a Bioanalyzer 2100 (Agilent, Waldbronn, Germany). All of the samples had a 260 nm/280 nm ratio between 1.8 and 2.1 and a 28S/18S ratio within 1.5-2.0 and were further processed. Total RNA samples (2 g) were reverse-transcribed into double-stranded cDNA, which was subsequently in vitro transcribed in presence of biotin-labeled nucleotides using an IVT Labeling Kit (P/N 900449; Affymetrix, Santa Clara, CA). The labeled cRNA was purified and quantified using BioRobot Gene Exp-cRNA Target Prep (Qiagen AG, Basel, Switzerland); its quality was determined using NanoDrop ND 1000 and Bioanalyzer 2100. Biotinlabeled cRNA samples (15 g) were fragmented randomly to bp at 94°C in fragmentation buffer (P/N 900371; Affymetrix) and were mixed in 300 l of hybridization buffer containing a hybridization Control cRNA and Control Oligo B2 (P/N 900454; Affymetrix), 0.1 mg/ml herring sperm DNA, and 0.5 mg/ml acetylated BSA in MES buffer, pH 6.7, and hybridized to GeneChip Rat Genome 230 2.0 arrays for 16 h at 45°C. Arrays were then washed using an Affymetrix Fluidics Station 450 EukGE-WS2v5_450 protocol. An Affymetrix GeneChip Scanner 3000 (Affymetrix) was used to measure the fluorescent intensity emitted by the labeled target.
Microarray Analysis
Microarray analysis was performed following the "minimum information about a microarray experiment" guidelines, and data are available at the Gene Expression Omnibus Database (http://www. ncbi.nlm.nih.gov/geo/) under the series number GSE12260. Normalization and computation of expression values were performed using the Robust Multichip Average algorithm (21) . In a first step, the statistically most relevant differentially regulated transcripts were identified using significance analysis of microarrays (SAM) (63), a method that provides a ranking of the transcripts found to be differentially regulated between any two given protocols. Statistical significance is measured by the q-value, which is the lowest false discovery rate (FDR) at which a gene is described as significantly regulated. The tolerance was set as 5%. FDR is the percentage of genes that are expected to be identified by chance. Here, we calculated the local FDR, which is the FDR for genes with scores that fall in a window around the score for a given gene. In SAM, a window of at least 50 genes is taken to estimate the local FDR at each point. In a second step, the association between DXR treatment and functionally related group of genes and pathways was studied using GSEA (55) . GSEA is a computational method that determines whether an a priori defined set of genes shows statistically significant, concordant differences between two biological states ("phenotypes"). Results are ranked by their normalized enrichment score, a P value, and the FDR (q-value). A searchable online collection of gene sets used with GSEA is available at The Molecular Signatures Database (http://www.broad.mit. edu/gsea/msigdb).
Real-Time RT-PCR
From microarray analysis, 13 genes covering a wide range of fold changes (0.2-4.0) in expression were selected for verification by a two-step, real-time RT-PCR: peroxisomal membrane protein 24 kDa (PMP24), tropomyosin 1, neural cell adhesion molecule 1, NADH dehydrogenase 1␣ subcomplex 10 (NDUFA10), opioid binding protein, muscle phosphofructokinase, carnitine palmitoyltransferase 2, glyceraldehyde-3-phosphate dehydrogenase, cardiac adriamycin responsive protein (CARP; ankyrin domain 1), growth arrest and DNAdamage-inducible 45␣ (GADD45␣), interleukin 1␣, dual-specificity phosphatase 1 (DUSP1), and heat shock protein 70 kDa (HSP70). Primers (see Supplemental Table 1 ) were purchased from Eurogentec (Seraing, Belgium). cDNA was synthesized from 1 g total RNA using Superscript III reverse transcriptase and oligo-dT as primer (Invitrogen, Carlsbad, CA). Real-time quantitative RT-PCR was performed in the Roche Light Cycler using Plus SYBR Green 1 Master Mix (Roche, Mannheim, Germany). Amplification reactions were conducted with an initial step at 95°C for 10 min followed by 30 -40 cycles. Cyclophilin A and tubulin alpha were used for normalization. The C t difference (⌬⌬Ct) was used for quantification of relative gene expression as 2
Ϫ⌬⌬Ct (37).
Western Blot Analysis
Forty micrograms protein was separated by SDS-PAGE and semi-dry blotted onto nitrocellulose membranes. After blocking in 4% milk, TBS, and 0.05% Tween 20 (alternatively 5% milk, TBS and 0.1% Tween 20), blots were immunostained for 2 h at room temperature or overnight at 4°C with following primary antibodies (dilutions): anti-CARP (1:100), anti-DUSP1 (1:200), anti-NDUFA10 (1:100), and anti-GAPDH (1:100) from Santa Cruz Biotechnology (Santa Cruz, CA); anti-HSP70 (1:500), anti-GADD45␣/␥ (1:500), anti-phospho-p38 MAPK (Thr180/Tyr182, 1:1,000), anti-phospho-ERK1/2 (Thr202/Tyr204, 1:1,000), and antiphospho JNK (Thr183/Tyr185, 1:1,000) from Cell Signaling (Beverly, MA); anti-ERK1/2 (1:1,000) from Upstate (Lake Placid, NY). Anti-PMP24 antibody (1:1,000) was generated in rabbits using a synthetic peptide antigen (EYHRPTLQPSLQSSMT) by Eurogentec. Secondary peroxidase-coupled antibodies were diluted (1:2,000 or 1:5,000) in blocking buffer, and blots were incubated for 1 h at room temperature. Blots were developed with Amersham ECL plus Western blotting detection reagents (GE Healthcare, Buckinghamshire UK).
Determination of ATP and Phosphocreatine
Adenine nucleotides and phosphocreatine (PCr) were extracted from the freeze-clamped hearts with ice-cold 0.6 N perchloric acid, centrifuged at 3,000 g for 12 min (4°C), neutralized to pH 6 -7 with 5 M K 2CO3, and centrifuged again at 3,000 g for 12 min (4°C). An enzymatic test was used to determine ATP and PCr (30) . Results were expressed in micromoles per gram dry weight.
Measurement of Mitochondrial Respiration in Skinned Fibers
Cardiac fibers were isolated from the hearts immediately after perfusion, as described previously (29, 47) , and mitochondrial respiration was measured with 2 mM malate/5 mM glutamate. We determined rates of basal respiration (without addition of external ADP, V 0), maximal coupled respiration (in presence of 2 mM ADP, Vmax), as well as dependency of respiration on external ADP (0.05-2 mM) and/or Cr (1-20 mM) to infer the corresponding apparent Michaelis constants: K m(ADP), apparent Km for ADP; Km Cr (ADP), apparent Km for ADP measured in presence of external Cr (20 mM); Km(Cr), apparent Km for Cr in the presence of ATP and an external ADP scavenging system. In the latter case, after initial stimulation of respiration by malate/glutamate and 2 mM ATP, PEP (5 mM), and PK (30 U/ml) were added to trap extramitochondrial ADP. Respiratory stimulation by Cr was then due to ADP regeneration in the mitochondrial intermembrane space by mitochondrial creatine kinase. In some experiments, cardiac fibers were treated with DXR directly in the oxygraph chamber (20 min preincubation and during measurements). Acceptor control ratio, calculated as V max/V0, served as an index of coupling of phosphorylation to oxidation. Normalized respiratory rates are given in nanomoles O 2 per minute per gram dry weight.
Statistical Analysis
If not stated otherwise, data are presented as means Ϯ SE. Statistical significance was evaluated by two-tailed Student's t-test using Microsoft Office Excel 2003. Differences with P Ͻ 0.05 were considered significant.
RESULTS
General Features of the Transcriptomic Response
Using a Langendorff model, we have analyzed the early transcriptomic response of rat hearts to 2-h perfusion with 2 M DXR. This represents a lower limit of DXR concentrations found in plasma of patients after bolus injection of the drug (18) . This perfusion induced modest but significant hemodynamic dysfunction (Fig. 1) . As in our previous study (60) , the two parameters end-diastolic pressure and ϪdP/dt were the most affected by the drug. This mild dysfunction was accompanied by distinct changes in the cardiac transcriptome as assessed at the end of perfusion. Microarray data were evaluated using both single-gene and gene set enrichment analysis (GSEA). Selective verification of microarray results by realtime PCR indicated a fairly good correlation between the two methods (Fig. 2) .
Both in terms of single genes and gene sets, gene expression was mostly downregulated in DXR-treated hearts (Fig. 3) . The distribution of fold changes of single genes is shown in Fig. 3A . A SAM with a FDR tolerance of 5% identified 87 upregulated genes with a fold change of at least 1.5 and 342 downregulated genes with a fold change of at least 0.67 (reciprocal of 1.5). Similarly, as shown in Fig. 3B , from a total of 1,068 gene sets analyzed, 226 were significantly downregulated in DXRtreated hearts (enriched in control hearts), while only 8 were significantly upregulated (enriched in DXR-treated hearts) at a nominal P value Ͻ1% (at P Ͻ 5% the numbers of downregulated and upregulated gene sets were 315 and 21, respectively). Thus, downregulation of gene expression is fairly widespread in DXR-treated hearts.
Single Gene Analysis
Selected single genes with a change in expression of at least 50% are shown in Table 1 ; (for complete single-gene analysis, see Supplemental Table 2 ). The corresponding gene products cover a large range of functions, but they can be tentatively assigned to some important groups. Many have functions related in a broader sense to cellular stress. Strikingly, expression of most of them was downregulated in the presence of DXR; some even belonged to the group of most strongly downregulated genes. Consistent downregulation was found for genes, whose products are directly involved in stress responses (like heat shock protein HSP70, the GADD45 family, some immediate early response genes) and antioxidative defense (like glutathione S-transferase M4 and glutamatecysteine ligase). Many genes related to immune response were also downregulated, including proinflammatory cytokines and their receptors (like interleukin 1-␣ and tumor necrosis factor ␣) with multifunctional roles in cell proliferation, induction of apoptosis, and inflammatory response, or selectin E that recruits neutrophils at sites of endothelial inflammation. More mixed responses were seen with different chemokine ligands, and upregulated transcripts included a myosin heavy chain class Ib antigen and some granzyme transcripts coding for serine proteases of cytotoxic immune cells. Since DXR targets DNA, the response of nucleic acid-related genes is particularly relevant. The group of genes related to nucleic acid synthesis, stability, and repair was mostly downregulated, with genes for histones and Kbtbd5, a potential DNA repair enzyme, belonging to the most strongly inhibited genes. However, two polymerases and the DNA repair enzyme nibrin were upregulated, possibly as a specific response to DNA damage.
DXR-repressed genes in heart remodeling/pathology and myofibrillar structure may reflect early DXR-induced damage occurring in the heart. Their gene products are linked to cardiac signaling and development, including the LIM protein dyxin that modulates cardiomyocyte growth, the actin-binding cardiomyopathy-associated protein Xirp1, and transcriptional coactivator Cited2. Again, some genes in these groups were upregulated, like osteoglycin and tropomyosin. Importantly, the only group of genes that was consistently upregulated was coding for metabolic enzymes like aldehyde dehydrogenase and NADH dehydrogenase.
Many other DXR-responsive genes code for cell-signaling components and were also predominantly downregulated (Table 1). These include protein kinases (e.g., polo-like kinase 2), protein phosphatases (e.g., protein phosphatase 1 regulatory subunit and dual-specificity phosphatase 1, DUSP1), G protein-signaling components (e.g., Rho family GTPases), transcription factors/regulators (e.g., Jun oncogene and activating transcription factor 3, ATF3). The few upregulated transcripts of these protein families include Jun D proto-oncogene, two phosphatases (PDH phosphatase and DUSP2) and a developmentally regulated GTP-binding protein. Many of these cellsignaling genes also respond to (oxidative) stress (e.g., ATF3 or DUSP) and regulate growth or apoptosis. This is also true for some other DXR-sensitive transcripts like upregulated quiescin Q6, coding for a sulfhyryl oxidase. The most strongly upregulated transcripts encode peroxisomal membrane protein 4, 24 kDa (PMP24) and a member of the ATP-binding cassette family.
Gene Set Enrichment Analysis
GSEA was applied to identify functionally related gene sets that respond to DXR in a coordinated manner. This method can detect relatively weak but significant coordinated changes. It is an especially valuable tool to get insight into biologically relevant signals in the early response to DXR, when changes in single genes are moderate and may escape analysis. Complete GSEA results can be found in Supplemental Table 3 . Selected gene sets are listed in Table 2 , and individual results of some gene sets are shown in Fig. 4 . Many of the top scoring single genes were also represented within the differentially regulated pathways, showing that the two analytic approaches are consistent and complementary. Fig. 4A ). Except hypoxia-suppressed genes, all responsive stress-related gene sets were downregulated, in particular, DNA damage signaling and cell signaling involving TNF, interleukin, and MAPK. Similarly consistent downregulation was found for gene sets in apoptotic signaling. Among the few DXR-induced gene sets were cardiac remodeling linked to c-Myc signaling (Table 2 ) and, importantly, two main pathways in energy metabolism, glycolysis, and TCA cycle ( Table 2 , Fig. 4B ).
Comparison Between mRNAs and Protein Expression/Phosphorylation
For seven DXR-affected transcripts, the corresponding protein abundance after 2-h perfusion with 2 M DXR was analyzed by immunoblotting (Fig. 5A ). Changes were significant only for two proteins, for which they paralleled transcript levels: HSP70 (decrease) and NDUFA10 (increase). Other examined protein levels were not yet altered or showed trends below a significant level. We further analyzed the phosphorylation status of three members of the MAPK family (p38, ERK1/2, and JNK), since some transcripts of this pathway were decreased in our model ( Table 2 , Fig. 4A ), while DXRinduced activation of this pathway was reported earlier (39, 52, 53, 72) . Indeed, ERK1/2 phosphorylation was considerably increased, while protein levels remained unchanged (Fig. 5B) . Phosphorylation of p38 and JNK was neither detectable in control nor in DXR-treated hearts.
Metabolic Status and Mitochondrial Function
Induction of gene expression by DXR likely involves more specific mechanisms compared with inhibition induced by DNA damage. Upregulated gene sets in energy metabolism may represent a compensatory or survival response to the onset of functional defects. We, therefore, determined cellular energy metabolites (ATP, PCr) and mitochondrial respiration in hearts perfused according to the same protocol as in microarray experiments (Table 3) . Although reduced cardiac ATP, PCr, and PCr/ATP ratios are known to occur after chronic DXR exposure or acutely upon higher DXR doses (for review, see Ref. 61 ), the perfusion with only 2 M DXR did not yet induce Gene ID, probe identifier as defined by Affymetrix or synonyms according to NCBI-Entrez gene (*). Well annotated genes whose expression changes by at least 50% are listed according to their general function. FC, fold change [doxorubicin (DXR) value divided by control value]; q-value (%), lowest false discovery rate at which a gene is described as significantly regulated; local FDR (%), local false discovery rate; SAM, significance analysis of microarrays. Results for the probe with the highest score are given. Light gray, downregulated compared to control; dark gray, upregulated compared to control; bold, the three most upregulated and downregulated genes. significant changes. Maximal ADP-stimulated respiratory rates and the kinetics of stimulation of mitochondrial respiration by ADP or/and Cr were determined in permeabilized fibers isolated from the hearts perfused without or with DXR. In an oxidative muscle such as the heart, the response of respiration to ADP and Cr is a sensitive indicator for the functional state of mitochondria and the efficiency of regulation of mitochondrial respiration and ATP production. Similarly, as for highenergy phosphates, the tendency toward altered respiratory parameters was not statistically significant under the given conditions, i.e., in hearts perfused with 2 M DXR ( Table 3 , Fig. 6A ).
However, when cardiac fibers were exposed to higher DXR doses (200 -500 M) directly in the oxygraph chamber, respiratory parameters were readily affected and supported the tendencies already observed with 2 M DXR (Fig. 6, A and B) . DXR at the highest dose significantly reduced the apparent K m (ADP) of respiration, indicating that tight regulation of mitochondrial permeability for ADP is lost. The most striking effects were seen with Cr-stimulated respiration, in which Cr is used by mitochondrial creatine kinase (MtCK) to regenerate ADP within mitochondria. This process involves metabolite channeling inside a microcompartment consisting of voltagedependent anion channel (outer membrane), MtCK (intermembrane space), and adenine nucleotide translocator (inner membrane) (48) 4. which shows that a cytosolic ADP-trapping system allows only mitochondrially generated ADP directly channeled from MtCK to ANT to stimulate respiration. The apparent K m (Cr) was already more than 3 times increased at 200 M DXR, and Cr stimulation of respiration was even completely abolished at 500 M DXR (Fig. 6B) .
DISCUSSION
This study aimed at a global characterization of the cardiac transcriptomic response to DXR to identify the most sensitive single genes and functionally related groups of genes. Such a nonbiased systems biology approach is expected to extend our knowledge of molecular events in acute DXR cardiotoxicity and to propose new mechanisms connecting acute DXR exposures with chronic pathology. Indeed, at a clinically relevant DXR concentration found also in patient's plasma after bolus injection (18) , an extensive transcriptomic reprogramming was observed already after 2 h of perfusion, while cardiac dysfunction was statistically detectable but still relatively mild. Transcriptomic profiling by single-gene comparison and gene set enrichment analysis identified essentially novel sets of DXRresponding cardiac genes. Roughly, the transcriptomic changes could be classified either as toxic, e.g., by suppressing cellular stress responses, or as compensatory and prosurvival, e.g., by A: representative downregulated gene sets, including the MAPK pathway, the "stress" pathway, the tumor growth factor beta (TGF-␤) pathway (related to plethora of cell functions, including immune response), and the LVAD-heart pathway (activated in the human failing heart in response to a left ventricular assist device, LVAD). B: representative upregulated gene sets, including the glycolysis pathway and the Krebs (TCA) cycle. Colored squares indicate the expression level of the indicated transcripts in four control and four DXR-treated hearts. Details on enrichment score and statistical significance are given in Table 2. favoring ATP generation. In conclusion, the inability to mount proper stress responses is proposed as a critical mechanism in DXR cardiotoxicity.
Cardiac Transcriptional Reprogramming by Doxorubicin Reveals Similarities to Cancer and Confirms Some Known Targets
The early transcriptional response of DXR-treated hearts showed prevalent downregulation of gene expression and selective upregulation of individual genes or gene sets. A similar pattern was reported for human breast carcinoma cells, with rapid gene repression and delayed but persisting gene induction (27) . Whether a transcriptomic change is specific or rather results from bulk DNA modification may depend on the individual gene. DXR exerts its inhibitory action on rapidly growing cancer cells by DNA intercalation and topoisomerase II inhibition, resulting in repression of DNA transcription and replication, as we have also observed in heart. However, topoisomerase inhibitors act in a gene-and context-dependent manner, with some promoter sequences and their target transcription factors being more vulnerable (11, 19, 28, 41) . Upregulation of genes certainly involves more specific mechanisms, which are much less understood so far.
Our unbiased study identified a large number of novel and potentially interesting DXR targets at the single-gene level. A rather comprehensive coverage of transcriptome changes is suggested by some strongly downregulated transcripts that were already found in earlier candidate-oriented approaches in heart or cancer. Our study identifies them as very susceptible and early responders. In the heart, these include heme oxygenase (4), natriuretic peptide precursor type B (9), TNF-␣ (38), and cardiac adriamycin-responsive protein [or cardiac ankyrin Values are expressed as means Ϯ SE (n ϭ 3 or 4), and P values for statistical significance are given. PCr, phosphocreatine; ACR, acceptor control ratio. For details, see MATERIALS AND METHODS.
repeat protein, CARP (24); missing in Table 1 since SAM fold change is 0.83]. Others were identified in cancer, such as the DUSP1 (52), confirming again similarities in the DXR response of heart and cancer.
Stress-Response Genes Are Repressed in Doxorubicin-Treated Hearts
DXR promotes oxidative stress, DNA intercalation, inflammation, and apoptosis. However, many genes generally induced by these stress conditions and involved in defense or compensatory mechanisms were paradoxically downregulated, as seen at the single-gene and the gene set level.
DNA damage. DXR is considered as a DNA damageinducing agent, but many pathways and transcripts normally induced by DNA damage were repressed. The entire p53-regulated and DNA damage-inducible Gadd45 family (Gadd45␣, Gadd45␤, and Gadd45␥) was downregulated. Gadd45 members were recently shown to have critical roles in negative cell growth control and apoptosis, e.g., by affecting the G2/M cell cycle checkpoint (71) .
Heat shock proteins. Heat shock proteins are molecular chaperones that have cytoprotective effects in a broad variety of adverse conditions. Reduced expression of the stress-inducible family member HSP70 and of the HSP27 pathway will reduce the stress response in the heart, corroborating DXR-induced downregulation of chaperones observed earlier in cancer (27) .
Immediate early response genes. Immediate early response genes are stress-inducible genes associated with the regulation of cell proliferation and apoptosis. They are typically induced by different forms of stress but were repressed by DXR in the heart.
Oxidative stress. DXR with its redox-cycling semiquinone ring is a strong inducer of oxidative stress. However, DXR reduced several transcripts related to antioxidant response: heme oxygenase, recently shown to protect cells from various insults, including oxidative stress (1, 46) ; glutamate-cysteine ligase, the rate-limiting enzyme in GSH biosynthesis; and glutathione S-transferase M4. The latter is a member of the large, multifunctional GST family acting in xenobiotic detoxification (including DXR) by conjugating them with GSH, and also as peroxidase, thus protecting cells from oxidative stress products (54) . Decreased antioxidative capacity of DXRtreated hearts was reported already earlier (15, 34, 35, 51) .
MAPK pathway. The stress-induced MAPK pathway is one of the major signaling pathways activated by DXR both in cardiac and cancer cells (39, 52, 53, 72) . However, we detected a coordinated repression of the MAPK pathway at the level of transcripts, confirming an earlier study (39) .
ATF3. Transcription factor ATF3 is a member of the ATF/ CREB family of transcription factors. It is rapidly induced by diverse environmental insults, including genotoxic stress, and affects protein stability and function via regulation of p53, thus maintaining DNA integrity and protecting against cell transformation. In our model, ATF3 was repressed by DXR.
HIF. The hypoxia-inducible stress response plays an essential role in triggering cellular protection under oxygen deprivation. In the DXR-perfused heart, the HIF pathway and the related VEGF pathway were repressed.
Immune system. Finally, immune and inflammatory systems ensure an efficient response to infections/pathogens. In our study, DXR induced multiple changes in the expression of genes controlling immune and inflammatory response by re- pressing numerous single genes and pathways and by inducing only a few (with granzymes B and C probably originating from cytotoxic T lymphocytes and natural killer cells). This mixed response is typical of the immunomodulatory role, mostly immunosuppressive but also immunogenic, often seen with anticancer drugs (2, 33) .
On the basis of these results and earlier reports, we propose that a blunted response to stress or reduced "danger signaling," seen here at the transcript level, is a prime component of toxic DXR action and can drive cardiac cells into pathology. This is consistent with our earlier observation made in a similar model of DXR-perfused heart, showing that DXR reduces protein and activation levels of AMP-activated protein kinase (AMPK), a key sensor and signaling hub in cellular and whole body energy homeostasis (58, 60) . Importantly, overexpression of some of the targeted stress-related genes (e.g., heat shock proteins, heme oxygenase, or ATF3) has shown promising results for in vitro protection against DXR-induced damage (13, 16, 36, 43, 45, 64) .
Doxorubicin Affects Genes Involved in Cardiac Damage and Remodeling
Other transcripts whose downregulation is directly detrimental to cardiac tissue may represent further potential targets for cardioprotection. These include LIM domain protein dyxin and Cited2, transcriptional regulators essential for normal heart development and function (3, 66) .
Cardiac remodeling is a compensatory mechanism of the heart to maintain cardiac output under stress that compromises cardiac function. It is associated with activation of specific genes that promote cardiac growth. DXR induced transcription of osteoglycin, identified as a major regulator of left ventricular mass (44) . DXR upregulated also transcripts controlled by c-Myc, a transcription factor whose activity has been associated with hypertrophic response in the heart (68). Moreover, DXR strongly repressed a group of genes implicated in reverse remodeling in response to mechanical unloading of the failing heart (LVAD, Fig. 4A ). Maintenance of these transcriptional effects may contribute to DXR-induced cardiac hypertrophy/ failure.
Upregulated "Energy-Related" Genes Indicate Fast Compensatory Mechanisms
In general, upregulation of transcripts can have cytotoxic or cytoprotective effects in cardiac and/or cancer cells. Both could be of therapeutic interest. Among the notable upregulated genes with known antiproliferative action in tumor growth are PMP24 and quiescin Q6 (QSCN6). Silencing of PMP24, the most strongly DXR-induced transcript, is associated with cancer progression (67) . Cytoprotective upregulation may be found in DNA synthesis/repair with polymerases and nibrin, in cardiac remodeling with tropomyosin 1␣ and osteoglycin, whose expression correlates with a cardiac hypertrophic response (44) , as well as in immune response and mainly in energy metabolism.
Gene sets related to energy metabolism (glycolysis and Krebs-TCA cycle) belonged to the few upregulated pathways. This is rather surprising, since acute DXR toxicity in cultured cardiomyocytes has been associated with suppression of several energy metabolism-related genes, including phosphofructokinase, ATP/ADP translocase, mitochondrial iron sulfur protein, and muscle creatine kinase (22, 25) , which was not observed in the model analyzed here. Our earlier studies in different molecular, cellular, and organ model systems also clearly evidenced an impairment of cell energetics by DXR, e.g., inhibition of energy signaling by AMPK or energy buffering and transfer by creatine kinases (59, 60) . In contrast, our transcriptome findings are partially congruent with the transcriptome response to DXR in a rat model, in which mitochondrial genes were widely repressed, but glycolytic genes were upregulated (5). Upregulation of glycolytic and Krebs cycle genes in the acute situation could be a transient, compensatory mechanism triggered by the very beginning of energetic dysfunction, known to develop during DXR cardiotoxicity (58, 61) . For example, in an earlier study in DXR-perfused heart, we also observed that a loss in cytosolic muscle-type creatine kinase was compensated by reexpression of brain-type creatine kinase, characteristic for early differentiation states (60) .
In DXR-perfused heart, early reprogramming in expression of "energy-related" genes was accompanied by fairly normal myocardial metabolic status and mitochondrial function. Even the response of mitochondrial respiration to ADP and creatine, a very sensitive indicator for the functional state of mitochondria, showed only subtle changes in terms of kinetics and related K m s. However, these changes further progressed and reached statistical significance upon higher DXR doses applied directly to the fibers, which is consistent with our previous results obtained with isolated mitochondria (57) . Thus, upregulation of "energy-related" genes and gene sets may precede the known DXR-induced energetic decline and represent a rather transitory compensatory mechanism. Failure of such compensatory mechanisms would then contribute to progressive accumulation of deficiencies in energy metabolism, a critical step in the deterioration of cardiac function.
Mechanisms responsible for specific early upregulation of energy-related genes would require very sensitive cellular sensors detecting minor changes in oxidative stress or energy state. AMPK is known to respond to minor changes in AMP/ ATP ratio that even escape statistical significance, but this pathway is inhibited by DXR (60) . Consistent with this finding, we observed downregulated expression of a set of AMPKregulated transcription factors, including PGC1-␣ (data not shown). Thus, DXR affects energy-related gene expression in an AMPK-independent manner that remains to be elucidated.
Complex Relationship Between mRNA and Protein Expression/Phosphorylation
Some transcriptomic changes already led to altered protein levels under our experimental conditions. Two out of seven proteins examined displayed significant changes that paralleled transcript levels: NDUFA10 and HSP70. The latter was found decreased after DXR treatment in vivo already earlier (50) . Other transcriptomic changes may be translated at a functional protein level only later, since DXR-induced changes in protein abundance are reported for some of them [HO-1 (4), TNF-␣ (38), DUSP1 (53) ]. DXR also affected protein phosphorylation, apparently before emerging transcriptomic changes are translated into protein levels. For example, DXR downregulated transcripts of the MAPK pathway, but it increased phosphorylation of ERK 1/2, a member of the MAPK family, consistent with earlier reports (39) and also consistent with downregulated transcripts of stress-induced DUSP1, a protein phosphatase selective for MAPK isoforms. However, downregulation of the MAPK pathway may become functionally important later. Reduced levels of upstream kinases within the MAPK pathway and increased DUSP2, another MAPK familyspecific protein phosphatase, could lead to ERK inactivation as observed by Lou et al. (39) in DXR-induced heart failure.
Novel Anticancer Strategies and Doxorubicin Treatment Share Similar Targets
Many identified genes not only respond similarly to DXR in heart and cancer, they also encode proteins that are suggested as targets of new anticancer therapies: heat shock proteins (8), the signaling pathway of MAP kinases (52), certain G proteins (56) , IGF (10), Wnt/␤-catenin (14, 40) , HIF (65), VEGF (26) , and TGF-␤, the latter playing a dual role of as tumor suppressor and prooncogenic factor (23) . Moreover, DXR has certain mechanistic details in common with a novel class of anticancer drugs, the tyrosine kinase inhibitors like imatinib mesylate (Gleevec) and gefitinib. DXR represses transcripts of pathways targeted by Gleevec and, similarly as gefitinib, induces expression of QSCN6, a gene that may play a role in tissue growth by affecting repartition between cells in the proliferative cycle, in quiescence, and in apoptosis (12, 69) .
The induction of c-Myc-activated genes is quite intriguing, given that this proto-oncogene is already overexpressed in many types of cancer, and we identified only a very limited number of upregulated pathways. Since c-Myc activity has a very complex impact on oncogenic transformation, it is difficult to anticipate the resulting phenotype. As seen in our study, the upregulated set of myc-related transcripts includes the well-established metastasis suppressor NM23A (7) . On the other hand, it has been demonstrated that combination of a DXR therapy with an inhibition of c-Myc transcriptional function has an enhanced anticancer effect (6) . It is also worthy to note that targeting these genes, which is supposed to be beneficial for cytotoxic action in cancer, may be rather detrimental to the heart.
Perspectives and Significance
We have performed a genome-wide screening of DXRinduced acute transcriptome changes in perfused heart, which identified cytotoxic, but also prosurvival responses. The acute repression of stress-responsive transcripts was a hallmark of the toxic response. In contrast, induction of glycolytic and Krebs cycle genes and modulation of gene expression for cardiac remodeling are rather a prosurvival response, indicating operation of fast compensatory mechanisms, which support the cardiac energetic network that is essential for heart functioning. The involved sensing and signaling mechanisms triggering the transcriptional reprogramming deserve further elucidation. The response of transcripts involved in cardiac remodeling and downregulation of stress-response genes could represent a link between acute DXR exposures and development of chronic cardiac injury, and these pathways might serve as targets for the new cardioprotective strategies. Identification of such networks of DXR-responsive targets will facilitate further mechanistic analysis of DXR toxicity in our model system but is also a prerequisite for future research in chronically drug-exposed animal models and in human hearts.
